Skin patch hepatitis B vaccine for healthy adults
Part of Digestive system, Infections clinical trials.
This trial tests a new way of giving the hepatitis B vaccine using a patch with tiny needles that goes on the skin. For healthy adults who have not been vaccinated against hepatitis B since childhood, this could be a more comfortable and easier way to protect against the infection.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 19 and 40 years old
- You should be in good overall health, with no active infections
- You must not have had a hepatitis B vaccine after childhood
- You cannot be pregnant, breastfeeding, or planning pregnancy during the trial
- You cannot have certain medical conditions like cancer, diabetes, or kidney issues
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new hepatitis B vaccine to see if it is safe and helps the body fight the virus. It is for healthy people who have not had a hepatitis B vaccine in the last 10 years.
This early-phase study tests whether a hepatitis B vaccine (with an added ingredient to boost the immune response) can safely help people with long-term hepatitis B who are already on antiviral therapy. It is mainly looking at safety and how the immune system responds.
This trial tests a new vaccine to treat chronic hepatitis B. It's for people who have been on antiviral medication for at least 6 months and still have a low level of the virus in their blood.
This study tests a new microneedle patch that delivers a tetanus booster vaccine through tiny needles in the skin, without a traditional shot. The patch is applied to the forearm, and the study checks its safety and how the body responds.
This trial tests an experimental vaccine to help your immune system fight chronic hepatitis B, with the goal of controlling or possibly curing the infection. It's a early-stage study, so the main goals are safety and finding the right dose.
This trial tests an experimental antibody treatment for people with chronic hepatitis B who have been on antiviral medication for at least 6 months. It aims to see if the antibody is safe and can help control the virus.
Hear when a new Hepatitis B Vaccine trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.